287 related articles for article (PubMed ID: 22951235)
21. Antidepressants: which to use first?
Lam RW
Can J Psychiatry; 1992 Oct; 37(8):592-3. PubMed ID: 1423167
[No Abstract] [Full Text] [Related]
22. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors.
López-Muñoz F; Alamo C; Juckel G; Assion HJ
J Clin Psychopharmacol; 2007 Dec; 27(6):555-9. PubMed ID: 18004120
[No Abstract] [Full Text] [Related]
23. [Pharmacological treatment of depression].
Castro P; Wilmotte J
Rev Med Brux; 1994; 15(5):306-10. PubMed ID: 7984847
[TBL] [Abstract][Full Text] [Related]
24. Revitalizing monoamine oxidase inhibitors: a call for action.
Gillman PK; Feinberg SS; Fochtmann LJ
CNS Spectr; 2020 Aug; 25(4):452-454. PubMed ID: 31272520
[No Abstract] [Full Text] [Related]
25. [Antidepressive agents in the treatment of masked moods].
Demling J
Fortschr Med; 1991 Sep; 109(27):540-4. PubMed ID: 1686603
[TBL] [Abstract][Full Text] [Related]
26. Antidepressants of the future.
Priest RG
Br J Psychiatry Suppl; 1989 Oct; (6):7-8. PubMed ID: 2619975
[No Abstract] [Full Text] [Related]
27. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
Kennedy SH
J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
[TBL] [Abstract][Full Text] [Related]
28. Moclobemide for depression.
Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
[TBL] [Abstract][Full Text] [Related]
29. The pharmacological management of depression.
Murphy S; Tyrer P
Int Rehabil Med; 1984; 6(2):vi-viii. PubMed ID: 6746200
[No Abstract] [Full Text] [Related]
30. The management of depression: a review of pharmacological and non-pharmacological treatments.
Johnson GF; Wilson P
Med J Aust; 1989 Oct; 151(7):397-400, 403, 406. PubMed ID: 2677623
[No Abstract] [Full Text] [Related]
31. [Treatment of depressive disorders].
Saiz Ruiz J; Ibáñez Cuadrado A
Rev Clin Esp; 1997 Nov; 197 Suppl 3():35-43. PubMed ID: 9477689
[No Abstract] [Full Text] [Related]
32. The role of monoamine oxidase inhibitors in depression treatment guidelines.
Thase ME
J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
[TBL] [Abstract][Full Text] [Related]
33. STAR*D: a summary and UK perspective.
Deakin J; O'Loughlin C
J Psychopharmacol; 2009 Aug; 23(6):605-12. PubMed ID: 19395428
[No Abstract] [Full Text] [Related]
34. [The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression].
Larsen JK; Krogh-Nielsen L; Brøsen K
Ugeskr Laeger; 2015 Dec; 177(52):V06150499. PubMed ID: 26692222
[TBL] [Abstract][Full Text] [Related]
35. Guidelines for the pharmacological management of depression.
Creelman W; Goethe JW
Conn Med; 1985 Sep; 49(9):565-9. PubMed ID: 4042649
[No Abstract] [Full Text] [Related]
36. The pharmacologic treatment of depression.
Potter WZ; Rudorfer MV; Manji H
N Engl J Med; 1991 Aug; 325(9):633-42. PubMed ID: 1861697
[No Abstract] [Full Text] [Related]
37. Improving results with antidepressant drug therapy.
Sussman N; Cancro R
Compr Ther; 1990 Feb; 16(2):12-23. PubMed ID: 2311358
[No Abstract] [Full Text] [Related]
38. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
[TBL] [Abstract][Full Text] [Related]
39. [Special aspects of antidepressive therapy].
Nervenarzt; 1994 Mar; 65(3 Suppl [speziell]):1-8. PubMed ID: 9218059
[No Abstract] [Full Text] [Related]
40. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics.
Fangmann P; Assion HJ; Juckel G; González CA; López-Muñoz F
J Clin Psychopharmacol; 2008 Feb; 28(1):1-4. PubMed ID: 18204333
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
